Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-26-054229
Filing Date
2026-05-01
Accepted
2026-05-01 17:00:21
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-05-01

Document Format Files

Seq Description Document Type Size
1 ARS iova-20251231xars.pdf ARS 5556936
  Complete submission text file 0001104659-26-054229.txt   7655644
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36860 | Film No.: 26933604
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)